A group of 23 Chinese swimmers was allowed to compete in the Tokyo Olympics despite testing positive for trimetazidine, a heart medication. The positive tests occurred during a pre-Olympic training camp, but Chinese anti-doping authorities cleared the swimmers, attributing the results to contamination. The 30-member Chinese swim team went on to secure six medals, including three golds. Both the World Anti-Doping Agency (WADA) and World Aquatics (previously known as FINA) were informed of the positive tests but agreed with the Chinese authorities' assessment of contamination.
Consequently, no sanctions were imposed on the athletes. World Aquatics expressed confidence in how the Adverse Analytical Findings (AAF) were handled, stating that all anti-doping regulations were followed. WADA's senior director of science and medicine, Professor Olivier Rabin, explained that WADA conducted a thorough review of the case before the Tokyo Games. This included consulting the manufacturer of trimetazidine for information on contamination scenarios.
Rohit Sharma Sets Sights on Future Cricket Glory: World Cups and WTC Finals
Summer HealthCare: Can Adding Salt to Drinking Water Prevent Dehydration?
